Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Head & Neck 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

pembrolizumab 302Carboplatin 155Nivolumab 154Cisplatin 139Cyclophosphamide 130Paclitaxel 127Magnetic Resonance Spectroscopy 98Specimen Handling 95Radiotherapy 90Gemcitabine 87Dexamethasone 83Biopsy 81Ipilimumab 78Docetaxel 75Doxorubicin 75Rituximab 69Etoposide 67atezolizumab 61durvalumab 60Lenalidomide 59Radiation 59Pemetrexed 58Taxes 57Bevacizumab 54Prednisone 54fludarabine 54olaparib 53Cytarabine 49Vincristine 49Fluorouracil 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Immunotherapy × 1 year × Clear all
NCT04454489 2025-11-19

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

Wake Forest University Health Sciences

Phase 2 Completed
21 enrolled 18 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03176173 2025-11-05

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Stanford University

Phase NA Completed
45 enrolled 13 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03426891 2025-10-06

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
21 enrolled 12 charts
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡